Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
8
×
life sciences
8
×
national blog main
san diego blog main
8
×
san diego top stories
biotech
boston blog main
boston top stories
detroit blog main
detroit top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
national
cancer immunotherapy
clinical trials
eli lilly
startups
deals
fda
merck
pfizer
abbvie
alzheimer's disease
boehringer ingelheim
bristol-myers squibb
What
companies
8
×
bio
roundup
life
drug
science
week
approved
biotechs
ipo
latest
merck
nash
new
news
pharmaceutical
price
sciences
therapeutics
admits
ago
alzheimer’s
approval
arena’s
big
biogen’s
biopharmaceutical
black
bounty
cancer
cig
classes
club
combinator
combo
comeback
continue
continued
convo
corner
Language
unset
Current search:
companies
×
cancer
×
" san diego blog main "
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
6 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M